CD8A and in situ carcinoma: An increase in the percentage of CD8 T cells expressing the activation markers CD26 and CD69 was described in patients with clinically isolated syndrome (CIS), a condition predisposing to MS, and MS patients with radiologically active disease compared to patients with inactive disease and healthy individuals (142).